
Lung cancer experts discuss successes and hesitations regarding the evolving use of antibody-drug conjugates in non–small cell lung cancer.

Your AI-Trained Oncology Knowledge Connection!


Susan Scott, MD, is a thoracic medical oncologist, at the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; as well as assistant professor of oncology at the Johns Hopkins University School of Medicine

Lung cancer experts discuss successes and hesitations regarding the evolving use of antibody-drug conjugates in non–small cell lung cancer.